common.study.topics.clinical

E-Cigarette Effects on Heart and Lung Disease

common.study.values.description

E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease

This study is designed to enhance the understanding of the possible health effects of e-cigarette use by relating the acute and long-term use of e-cigarettes and conventional cigarettes ("products") to well-validated cardiovascular and pulmonary disease biomarkers. Participants will be enrolled in 4 groups: exclusive e-cigarette users, exclusive cigarette smokers, e-cigarette and cigarette users, and a control group of never-users. Participants can expect up to 4 weeks of study participation.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Behavioral - Cigarettes

smokes daily

Behavioral - E-Cigarettes

E-cigarette usage >/= 5 days/week

participant.views.study.view.additional

participant.views.study.view.scientific-title

E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease Risk (Aka CLUES - Cardiac and LUng E-cig Smoking Study)

common.study.values.clinical-trial-id

NCT03863509

participant.views.study.view.id

e0RMVb